Title: The Innovative Mind of Jean-Marc Treluyer
Introduction
Jean-Marc Treluyer is an accomplished inventor based in Paris, France. He has made significant contributions to the field of drug dosing regimens, focusing on optimizing treatment for patients. Although he currently holds no granted patents, his work demonstrates a commitment to advancing medical science.
Latest Patent Applications
Jean-Marc Treluyer's notable patent application is titled "Method for Determining an Optimal Drug Dosing Regimen." This invention concerns a method for determining an optimum drug dosing regimen to treat a patient efficiently against drug-sensitive pathogenic agents. The method utilizes relevant patient-related data and the drug concentration measured at a random time in the patient's body. It estimates the drug concentration time-course based on a Bayesian model. The residual concentration (C) and an efficiency pharmacokinetic parameter (PPE) adapted to the drug and patient are computed from the estimated concentration. A dosing regimen is then determined by comparing the PPE to an efficiency target (CE) for efficiency purposes. The method may also take into account toxicity constraints by comparing the residual drug concentration (C) to at least a toxic concentration (C). A concentration of the drug is determined (E) based on the results of the above comparisons to provide a proposed dose for the optimum dosing regimen.
Conclusion
Jean-Marc Treluyer's innovative approach to drug dosing regimens highlights his dedication to improving patient care through scientific advancements. His work has the potential to significantly impact the medical field, paving the way for more effective treatments.